Nutshell Therapeutics has garnered $20 million in a Series A round of funding led by Matrix Partners China. In a separate development, Kolmostar has secured about 100 million yuan ($16 million) in a Series A+ round led by CTC Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
